Thatch Integrates Genomics into Benefits Marketplace, Expanding Precision Health Access
Event summary
- Thatch, a benefits platform utilizing Individual Coverage Health Reimbursement Arrangements (ICHRAs), has partnered with MyOme, a genomics company, to integrate MyOme's Proactive Health (MPH) platform into its Marketplace.
- The MPH platform offers single-gene risk insights, pharmacogenomics guidance, and polygenic risk scores for conditions like heart disease.
- Thatch has helped over 1,000 companies since 2023 manage healthcare costs and improve coverage.
- The collaboration aims to lower the barriers to genomic screening for employers and employees, addressing rising healthcare costs and a demand for personalized benefits.
The big picture
The partnership reflects a growing trend of integrating personalized medicine into employee benefits packages, driven by employer pressure to control healthcare costs and attract talent. ICHRAs are gaining traction as a flexible benefits solution, and the addition of genomics represents a significant advancement in personalized healthcare offerings. MyOme's ability to scale its genomic insights through Thatch’s existing platform could significantly impact the accessibility and affordability of precision health.
What we're watching
- Adoption Rate
- The success of this partnership hinges on Thatch members’ adoption of MyOme’s MPH platform, which will dictate the realized cost savings and impact on employee health outcomes.
- Data Privacy
- The integration of genomic data raises significant privacy and security concerns, and how Thatch and MyOme address these will be critical to maintaining trust and regulatory compliance.
- Expansion Scope
- The expansion of disease areas covered by MyOme’s iPRS will determine the long-term value proposition for employers and employees, and potentially influence broader adoption of genomic-based benefits.
Related topics